Randomized controlled trial of sativex, a cannabis based medicine (CBM), in central neuropathic pain due to multiple sclerosis, followed by an open-label extension

Authors
Category Primary study
JournalNeurology
Year 2006
This article has no abstract
Epistemonikos ID: 9faf42f3d46fab9a283613db0814a2a409ba22fc